Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

Stigma connected with Alzheimer’s disease may create barriers for individuals seeking information about their risk of the disease and discourage them from participating in clinical studies that could ...

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...

With a disease as difficult and devastating as Alzheimer's disease, we want to do everything we can to delay and prevent progression. Not everything marketed for memory and other symptoms of the ...

A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

Scientists have found that the anti-seizure medication levetiracetam prevents the buildup of faulty amyloid-beta proteins in the brain, which could help prevent Alzheimer's disease.

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...

Scientists discover aloe vera compound could offer breakthrough Alzheimer's treatment. Beta sitosterol shows promising results in computer simulations.

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.